Balance Sheet for Portola Pharmaceuticals Inc. (PTLA)

$ 18.03 0.00 (0.00%) Volume: 0 4:00 PM EDT 15-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 215,229 138,951 181,568 188,480 186,488
Restrictable Cash 3,421 1,062 173 178 341
Marketable Securities 214,054 178,013 281,589 130,291 257,713
Accounts Receivable 13,547 5,849 3,750 - 1,000
Loans Receivable - - - - -
Other Receivables 3,783 9,880 - - -
Receivables 17,330 15,729 3,750 - 1,000
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - 10,079 1,032 - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - 251 67 - -
Inventories, Other 4,101 7,873 1,099 - -
Inventories, Adjustments & Allowances - - - - -
Inventories 4,101 7,873 1,099 - -
Prepaid Expenses 7,998 11,699 9,744 9,979 20,035
Current Deferred Income Taxes - - - - -
Other Current Assets - 333,755 477,189 321,629 448,601
Total Current Assets 462,133 353,327 477,923 328,928 465,577
Land and Improvements - - - - -
Buildings and Improvement 8,304 8,143 8,000 7,529 7,529
Machinery, Furniture and Equipment 12,086 11,394 9,820 9,523 7,699
Construction in Progress - - - - -
Fixed Assets, Other 12,064 - - - -
Fixed Assets, Total 32,454 19,537 17,820 17,052 15,228
Gross Fixed Assets 32,454 19,537 17,820 17,052 15,228
Accumulated Depreciation (16,126) (14,301) (12,603) (10,909) (8,985)
Net Fixed Assets 16,328 5,236 5,217 6,143 6,243
Intangibles 14,680 7,279 7,851 3,151 3,151
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 56,096 9,645 88,536 8,365 31,104
Total Non-Current Assets 116,350 33,092 93,753 14,508 37,347
Total Assets 578,483 386,419 571,676 343,436 502,924
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 12,739 13,215 9,304 14,546 10,279
Short Term Debt 23,749 11,802 - - -
Notes Payable - - - - -
Accrued Expenses 35,167 25,296 48,525 25,514 25,484
Accrued Liabilities 35,167 25,296 48,525 25,514 25,484
Deferred Revenues 1,623 1,847 11,169 20,798 8,387
Current Deferred Income Taxes - - - - -
Other Current Liabilities 29,140 16,845 11,526 4,806 6,996
Total Current Liabilities 102,418 69,005 80,524 65,664 51,146
Long Term Debt 324,093 203,554 104,816 49,815 -
Deferred Income Tax 4,352 4,488 18,798 24,965 18,629
Other Non-Current Liabilities 13,297 23,293 36,843 35,268 21,455
Minority Interest - 2,166 2,627 2,157 2,927
Capital Lease Obligations 8,850 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 346,240 229,013 144,286 87,240 24,382
Total Liabilities 448,658 298,018 224,810 152,904 75,528
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 129,825 88,401 346,866 190,532 427,396
Common Par 80 68 66 57 57
Additional Paid in Capital 1,946,077 1,614,320 1,551,728 1,108,832 1,076,791
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,816,367) (1,525,704) (1,204,519) (918,345) (649,302)
Treasury Stock - - - - -
Other Equity Adjustments 35 (283) (409) (12) (150)
Total Capitalization 453,918 291,955 451,682 240,347 427,396
Total Equity 129,825 88,401 346,866 190,532 427,396
Total Liabilities & Shareholder's Equity 578,483 386,419 571,676 343,436 502,924
Cash Flow (297,875) (351,782) (287,795) (271,150) (230,991)
Working Capital 359,715 284,322 397,399 263,264 414,431
Free Cash Flow (239,467) (328,617) (231,361) (198,319) (211,998)
Invested Capital 453,918 291,955 451,682 240,347 427,396
Shares Outstanding - Common Class Only 77,925 66,618 65,297 56,544 56,360
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 77,925 66,618 65,297 56,544 56,360
Total Common Shares Outstanding 77,925 66,618 65,297 56,544 56,360
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 71,555 66,017 59,508 56,481 51,981
Diluted Weighted Shares Outstanding 71,555 66,017 59,508 56,481 51,981